GO:0030184 nitric oxide transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030184 describes the molecular function of enabling the transfer of nitric oxide (nitrogen monoxide) from one side of a membrane to the other.
• Nitric oxide is a small, diffusible free radical that modulates cardiac neuronal activity and cardiovascular function.
• Transport of nitric oxide across membranes can occur via direct diffusion or through specialized channels and transporters.
• Nitric oxide signaling is implicated in cirrhotic cardiomyopathy and ischemic cardiovascular diseases [1,4].
• Cellular levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, regulate nitric oxide bioavailability.
• Studying GO:0030184 requires methods such as knockout models, point mutations, and live-cell imaging of nitric oxide flux [7,8].
Description
GO:0030184, nitric oxide transmembrane transporter activity, is a molecular function term in the Gene Ontology that describes the transfer of nitric oxide (nitrogen monoxide) from one side of a membrane to the other. Nitric oxide is a short-lived free radical gas that acts as a signaling molecule in diverse physiological processes, including cardiovascular regulation and neuronal communication. Because nitric oxide is membrane-permeable, its transport can occur via simple diffusion, but emerging evidence indicates that specialized membrane proteins, such as connexin hemichannels, can facilitate its transmembrane movement. Understanding this transport activity is critical for researchers studying nitric oxide signaling in health and disease. Altered nitric oxide transport and signaling have been linked to conditions such as cirrhotic cardiomyopathy and ischemic cardiovascular diseases [1,4]. Moreover, endogenous inhibitors like ADMA can modulate nitric oxide production and availability, indirectly affecting its transport and downstream effects. This article provides a research-grade overview of GO:0030184, covering its definition, mechanism, key genes, disease relevance, and experimental approaches for investigation.
nitric oxide transmembrane transporter activity At A Glance
| GO ID | GO:0030184 |
|---|---|
| GO term | nitric oxide transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of nitric oxide from one side of a membrane to the other |
| Substrate | Nitric oxide (nitrogen monoxide) |
| Directionality | Transmembrane transfer (bidirectional or unidirectional depending on context) |
| Associated processes | Nitric oxide signaling, cardiovascular regulation, neuronal modulation |
| Related diseases | Cirrhotic cardiomyopathy, ischemic cardiovascular diseases, cataract formation |
What Is GO:0030184?
According to the Gene Ontology, GO:0030184 (nitric oxide transmembrane transporter activity) enables the transfer of nitric oxide, also known as nitrogen monoxide, from one side of a membrane to the other. This activity is classified as a molecular function and involves the movement of nitric oxide across biological membranes, which may occur through direct diffusion or via protein-mediated transport [1,8].
Why Is nitric oxide transmembrane transporter activity Important in Cell Biology?
Nitric oxide transmembrane transporter activity is important because it directly influences the spatial and temporal distribution of nitric oxide, a key signaling molecule involved in cardiovascular, neuronal, and immune functions. Dysregulated nitric oxide transport can contribute to disease pathogenesis, including cirrhotic cardiomyopathy and ischemic cardiovascular diseases [1,4]. Additionally, proteins that facilitate nitric oxide transport, such as connexin hemichannels, are implicated in cataract formation, highlighting the broad physiological relevance of this activity.
• Regulates nitric oxide availability for signaling in the cardiovascular system.
• Modulates intrinsic cardiac neuronal activity and cardiodynamic changes.
• Influenced by endogenous inhibitors like ADMA, affecting nitric oxide bioavailability.
• Linked to cirrhotic cardiomyopathy, a complication of liver cirrhosis.
• Implicated in ischemic cardiovascular diseases and potential therapeutic strategies.
• Connexin hemichannels can facilitate nitric oxide transport, with roles in lens physiology and cataract formation.
• Nitric oxide transport affects oxidative stress responses, potentially interacting with p53 regulation.
• Cannabinoid receptor signaling may intersect with nitric oxide pathways, though direct evidence for transport is limited.
• Calcium crystal-induced inflammation involves nitric oxide, suggesting a role in inflammatory joint diseases.
• Understanding transport mechanisms aids in drug development targeting nitric oxide signaling.
What Happens During nitric oxide transmembrane transporter activity?
Nitric oxide synthesis and release
In simple terms: Nitric oxide is made inside cells and then released.
Nitric oxide is synthesized by nitric oxide synthases from L-arginine. Once produced, it can diffuse within the cell or be released to the extracellular space. The release step is a prerequisite for transmembrane transport.
Interaction with membrane components
In simple terms: Nitric oxide encounters the cell membrane and may interact with proteins that help it cross.
Due to its small size and lipophilic nature, nitric oxide can diffuse through lipid bilayers. However, specific membrane proteins, such as connexin hemichannels, can facilitate its transmembrane movement. For example, Cx46 hemichannels are modulated by nitric oxide, and a cysteine residue in the fourth transmembrane helix is involved in this regulation.
Transmembrane transfer
In simple terms: Nitric oxide moves from one side of the membrane to the other.
The actual transfer of nitric oxide across the membrane can occur via passive diffusion or through protein-mediated transport. The direction and rate depend on concentration gradients and the presence of transporters. This step defines the molecular function GO:0030184.
Downstream signaling
In simple terms: Once across, nitric oxide can affect target cells.
After crossing the membrane, nitric oxide can activate soluble guanylate cyclase, modulate ion channels, or interact with other signaling molecules. In the heart, nitric oxide donors modulate intrinsic cardiac neuronal activity, leading to cardiodynamic changes.
Key Genes Involved in GO:0030184 nitric oxide transmembrane transporter activity
The following genes and proteins are involved in nitric oxide transmembrane transporter activity or related nitric oxide signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cx46 (GJA3) | Connexin hemichannel; facilitates nitric oxide transport; modulated by nitric oxide via cysteine residue | Studied in cataract formation and lens physiology |
| NOS1 (nNOS) | Neuronal nitric oxide synthase; produces nitric oxide | Involved in neuronal signaling and cardiac regulation |
| NOS2 (iNOS) | Inducible nitric oxide synthase; produces nitric oxide in inflammation | Linked to inflammatory diseases and oxidative stress |
| NOS3 (eNOS) | Endothelial nitric oxide synthase; produces nitric oxide in vasculature | Critical for cardiovascular homeostasis |
| PRMT1 | Protein arginine methyltransferase; generates ADMA, an endogenous NOS inhibitor | Regulates nitric oxide bioavailability |
| DDAH1 | Dimethylarginine dimethylaminohydrolase; degrades ADMA | Modulates nitric oxide synthesis and transport |
| DDAH2 | Dimethylarginine dimethylaminohydrolase; degrades ADMA | Modulates nitric oxide synthesis and transport |
| TP53 | Tumor suppressor; regulates oxidative stress responses | May influence nitric oxide signaling in skeletal muscle |
| CNR1 | Cannabinoid receptor 1; signaling may intersect with nitric oxide pathways | Potential crosstalk in cardiovascular and neuronal systems |
| CNR2 | Cannabinoid receptor 2; signaling may intersect with nitric oxide pathways | Potential crosstalk in immune and cardiovascular systems |
| MAS1 | Mas receptor; involved in ischemic cardiovascular diseases | Potential strategy in cardiovascular therapy |
| ACE2 | Angiotensin-converting enzyme 2; related to Mas receptor pathway | Cardiovascular protection |
| CALCA | Calcitonin-related polypeptide; involved in calcium crystal-induced inflammation | Inflammation and pain |
| TRPV1 | Transient receptor potential vanilloid 1; calcium channel | Inflammation and nitric oxide signaling |
| GUCY1A1 | Soluble guanylate cyclase subunit; target of nitric oxide | Downstream signaling |
| GUCY1B1 | Soluble guanylate cyclase subunit; target of nitric oxide | Downstream signaling |
| HIF1A | Hypoxia-inducible factor 1-alpha; regulates NOS expression | Ischemic cardiovascular diseases |
How Is nitric oxide transmembrane transporter activity Regulated?
Nitric oxide transmembrane transporter activity is regulated at multiple levels. The availability of nitric oxide for transport is controlled by its synthesis via nitric oxide synthases and its degradation. Endogenous inhibitors such as asymmetric dimethylarginine (ADMA) competitively inhibit NOS, thereby reducing nitric oxide production and subsequent transport. Additionally, the activity of connexin hemichannels, which can facilitate nitric oxide transport, is modulated by nitric oxide itself through post-translational modifications, such as S-nitrosylation of cysteine residues. In the cardiovascular system, neuronal activity and cardiodynamic changes can be influenced by nitric oxide donors, indicating that neuronal signaling pathways regulate nitric oxide release and transport. Furthermore, oxidative stress and p53 activity may impact nitric oxide signaling in skeletal muscle, suggesting a role for redox regulation.
nitric oxide transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Cx46 (GJA3) | Cataract formation | Knockout or point mutation in lens epithelial cells |
| NOS3 (eNOS) | Ischemic cardiovascular diseases | Endothelial cell knockout or overexpression |
| DDAH1 | Cardiovascular disease via ADMA regulation | Knockout mouse model |
| TP53 | Oxidative stress in skeletal muscle | Knockout or point mutation in myoblasts |
| CNR1 | Cardiovascular and neuronal signaling | Knockout or overexpression in neurons |
Cirrhotic Cardiomyopathy
Cirrhotic cardiomyopathy is a cardiac dysfunction observed in patients with liver cirrhosis. Nitric oxide plays a key role in its pathogenesis, and altered nitric oxide transport and signaling contribute to cardiac abnormalities. The condition is characterized by impaired contractility and diastolic dysfunction.
Ischemic Cardiovascular Diseases
Ischemic cardiovascular diseases involve reduced blood flow to the heart. The Mas receptor pathway, which interacts with nitric oxide signaling, is a potential therapeutic target. Nitric oxide transport and bioavailability are critical for endothelial function and cardioprotection.
Cataract Formation
Cataract formation in the lens is associated with oxidative stress and impaired nitric oxide signaling. Connexin hemichannels, such as Cx46, facilitate nitric oxide transport and are modulated by nitric oxide. Mutations or dysregulation in these channels may contribute to cataract development.
Inflammatory Joint Diseases
Calcium crystal-induced inflammation, such as gout and pseudogout, involves nitric oxide as a mediator. Nitric oxide transport and signaling participate in the inflammatory response, and modulating these pathways may offer therapeutic benefits.
From nitric oxide transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X facilitate nitric oxide transport? | Knockout cell line (e.g., Cx46 KO) |
| What is the role of a specific cysteine in nitric oxide transport? | Point mutation (e.g., Cx46 Cys mutant) |
| Can a tagged transporter be visualized in live cells? | Knock-in of fluorescent tag (e.g., GFP-Cx46) |
| Does overexpression of NOS increase nitric oxide transport? | Overexpression of NOS3 in endothelial cells |
| What is the effect of ADMA on nitric oxide transport? | Treatment with ADMA in wild-type and DDAH1 KO cells |
| Does p53 regulate nitric oxide transport under oxidative stress? | p53 knockout or point mutant myoblasts |
How to Study the nitric oxide transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DAF-FM fluorescence | Intracellular nitric oxide levels | Live-cell imaging of transport |
| Patch clamp | Hemichannel currents | Assessing Cx46-mediated transport |
| Dye uptake assay | Hemichannel permeability | Screening for transport inhibitors |
| HPLC for ADMA | ADMA concentration | Regulation of NOS and transport |
| Citrulline conversion | NOS enzymatic activity | Nitric oxide synthesis rate |
| Western blot | Protein expression levels | Knockout validation |
| qRT-PCR | mRNA expression | Gene expression analysis |
| CRISPR screening | Gene essentiality for transport | High-throughput discovery |
Live-cell imaging of nitric oxide
Fluorescent probes such as DAF-FM can detect intracellular nitric oxide levels. By using compartmentalized probes, researchers can monitor nitric oxide transport across membranes in real time.
Electrophysiology and hemichannel activity
Connexin hemichannel activity can be measured by patch clamp or dye uptake assays. These methods help assess whether nitric oxide transport is mediated by hemichannels.
Genetic knockout and rescue
Knockout of candidate transporter genes followed by rescue with wild-type or mutant constructs can establish causality. For example, Cx46 knockout cells show altered nitric oxide transport, which can be rescued by wild-type Cx46 but not by a cysteine mutant.
Biochemical assays for ADMA and NOS activity
ADMA levels can be measured by HPLC or ELISA, and NOS activity by citrulline conversion assays. These methods link nitric oxide synthesis and transport regulation.
How CRISPR Can Be Used to Study GO:0030184 nitric oxide transmembrane transporter activity
Knockout
CRISPR knockout of candidate genes such as Cx46 can abolish nitric oxide transport, as measured by live-cell imaging or dye uptake. This approach identifies essential transporters.
Point Mutation
Introducing point mutations, such as cysteine to serine in Cx46, can test the role of specific residues in nitric oxide transport. Mutants are expressed in knockout backgrounds to assess function.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci allows visualization of transporter localization and dynamics in live cells. This can reveal membrane trafficking and interaction with nitric oxide.
Overexpression
Overexpression of nitric oxide synthases or transporters can increase nitric oxide production and transport, enabling studies of downstream signaling and disease models.
How EDITGENE Supports nitric oxide transmembrane transporter activity Research
Researchers studying nitric oxide transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in nitric oxide transport, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for nitric oxide transmembrane transporter activity research.
Frequently Asked Questions About nitric oxide transmembrane transporter activity
What is GO:0030184?
GO:0030184 is the Gene Ontology term for nitric oxide transmembrane transporter activity, which enables the transfer of nitric oxide from one side of a membrane to the other.
What genes are involved in nitric oxide transmembrane transporter activity?
Genes such as Cx46 (GJA3), NOS1, NOS2, NOS3, DDAH1, and DDAH2 are involved in nitric oxide transport or its regulation [6,8].
How is nitric oxide transported across membranes?
Nitric oxide can diffuse through lipid bilayers or be facilitated by membrane proteins such as connexin hemichannels.
What diseases are associated with nitric oxide transport?
Diseases include cirrhotic cardiomyopathy, ischemic cardiovascular diseases, and cataract formation [1,4,8].
What is the role of ADMA in nitric oxide transport?
ADMA inhibits nitric oxide synthases, reducing nitric oxide production and thus its availability for transport.
How can I study nitric oxide transmembrane transporter activity?
Methods include live-cell imaging with DAF-FM, patch clamp of hemichannels, and CRISPR knockout models [7,8].
What is the function of Cx46 in nitric oxide transport?
Cx46 hemichannels can facilitate nitric oxide transport and are modulated by nitric oxide via a cysteine residue.
Is nitric oxide transport passive or active?
It is primarily passive, driven by concentration gradients, but can be facilitated by proteins [1,8].
What are the synonyms for GO:0030184?
There are no synonyms listed for GO:0030184 in QuickGO.
How does p53 affect nitric oxide transport?
p53 regulates oxidative stress, which can influence nitric oxide signaling and potentially transport in skeletal muscle.
Conclusion
GO:0030184, nitric oxide transmembrane transporter activity, is a fundamental molecular function that governs the movement of nitric oxide across membranes. This activity is critical for nitric oxide signaling in cardiovascular, neuronal, and inflammatory processes. Dysregulation of nitric oxide transport is linked to diseases such as cirrhotic cardiomyopathy, ischemic cardiovascular diseases, and cataract formation. Advances in CRISPR-based models and live-cell imaging are enabling researchers to dissect the molecular mechanisms and identify therapeutic targets. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Møller S et al.. 2010. Cirrhotic cardiomyopathy.. J Hepatol 53(1):179-90 PMID: 20462649
- 2. Halverson PB et al.. 2001. Calcium crystal-induced inflammation.. Curr Opin Rheumatol 13(3):221-4 PMID: 11333353
- 3. Howlett AC. 2005. Cannabinoid receptor signaling.. Handb Exp Pharmacol PMID: 16596771
- 4. Molaei A et al.. 2023. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.. Cell Cycle 22(13):1654-1674 PMID: 37365840
- 5. Beyfuss K et al.. 2018. A systematic review of p53 regulation of oxidative stress in skeletal muscle.. Redox Rep 23(1):100-117 PMID: 29298131
- 6. Teerlink T et al.. 2009. Cellular ADMA: regulation and action.. Pharmacol Res 60(6):448-60 PMID: 19682580
- 7. Armour JA et al.. 1995. Modulation of intrinsic cardiac neuronal activity by nitric oxide donors induces cardiodynamic changes.. Am J Physiol 268(2 Pt 2):R403-13 PMID: 7864235
- 8. Retamal MA et al.. 2019. Cx46 hemichannel modulation by nitric oxide: Role of the fourth transmembrane helix cysteine and its possible involvement in cataract formation.. Nitric Oxide 86:54-62 PMID: 30797972
